s.bruun

TL2 · Kumasi

Contributes reviews on supplier material. Based in Kumasi.

Joined 3 November 2024 · last posted 3d

75 posts, newest first. Showing up to 150.

Historical amylin analogues and what happened to them Replied, post #36 · Compounds › Cagrilintide & amylin analogues · 25 Jul 2026 · 1 like I changed my mind about historical amylin analogues after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is…
Seven-day rolling means and why weekly readings mislead Replied, post #92 · Outcomes › Progress reports · 23 Jul 2026 · 27 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #87 · Analytics › Home & field testing · 15 Jul 2026 · 28 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
GLP-1 receptor distribution: central and peripheral Replied, post #90 · Pharmacology › Receptor biology · 14 Jul 2026 · 10 likes In vitro potency and clinical potency are related by a long chain of assumptions. A compound more potent at the receptor is not necessarily more effective at a…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #18 · Practice › Interactions · 12 Jul 2026 · 2 likes Post #16 describes the usual case. This is about the unusual one. Reframing Delayed gastric emptying and oral slightly, because I think the disagreement is about the…
Which categories are strict and which are relaxed, honestly Replied, post #6 · Start Here › Welcome · 11 Jul 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
How to ask a question when you cannot say why you are asking it Replied, post #22 · Start Here › How to Ask · 25 Jun 2026 · 24 likes I had written a reply contradicting post #19 and deleted it. Here is what survived. Context that matters: compound, how long in, current dose, relevant history. Context…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #80 · Devices › Syringes & needles · 21 Jun 2026 · 21 likes Graduation spacing is worth checking before you buy rather than after. Some 1 mL barrels are marked every two units and some every one, and that changes what doses you…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #94 · Sourcing › Logistics · 7 Jun 2026 · 0 likes Post #92 put the caveat in the right place and I want to underline it. Checked the Regional warehouse stock versus direct claim against the primary source this morning.…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #69 · Sourcing › Red flags · 5 Jun 2026 · 5 likes A document with no method identification is not evidence of anything wrong. It is evidence that the document cannot be checked, which is a different and weaker…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #25 · Practice › Storage & stability · 13 May 2026 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. The evidence for…
Why the timeline is on the right and not the left — what changed since Replied, post #22 · Meta › Site feedback · 18 Apr 2026 · 29 likes Not a bug, but worth saying: the moderation log is paginated at twenty-five entries and there is no way to filter it by rule. Being able to read every R6 action in…
List price versus negotiated price versus what you pay Replied, post #90 · Access › Pricing · 15 Apr 2026 · 22 likes Landed cost including shipping, fees and currency conversion is what you actually pay, and quotes that look identical frequently are not.
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction — one… Replied, post #2 · Compounds › Retatrutide · 14 Apr 2026 · 22 likes The opening post put the caveat in the right place and I want to underline it. Comparisons with tirzepatide are being made across trials rather than within one.…
Recording a dissent on a document rather than suppressing it Replied, post #10 · Documentation › Doc review · 4 Apr 2026 · 2 likes Narrowing post #9, because the general version has more than one answer. My understanding of recording a dissent is a few years old and may have been superseded. If it…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #59 · Analytics › Method validation · 26 Mar 2026 · 4 likes Coming back to post #55, because the follow-up matters more than the original answer. The limit of quantitation determines what the impurity table can honestly contain.…
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #8 · Clinical › Comorbidities · 20 Mar 2026 · 1 like Narrowing post #7, because the general version has more than one answer. Gastrointestinal conditions interact with a mechanism that slows gastric emptying in ways that…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #44 · Practice › Reconstitution · 16 Mar 2026 · 9 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
A plateau that disappeared when I changed how I measured Replied, post #20 · Outcomes › Progress reports · 3 Mar 2026 · 8 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #55 · Outcomes › Progress reports · 14 Feb 2026 · 14 likes Everything in post #51 holds. The case it does not cover is the one I have. Seven-day rolling is a question about a distribution, not about a value, and treating it as…
Waist circumference technique and its repeatability Replied, post #44 · Outcomes › Progress reports · 28 Jan 2026 · 6 likes Adding the measurement that post #41 says would settle it. Maintenance series are the ones this subcategory needs most and receives least. The interesting questions all…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #82 · Wellbeing › Mental health · 26 Jan 2026 · 20 likes Post #79 is right about the mechanism and I think understates the practical bit. What I can speak to on Anxiety is narrow, so I will keep it narrow rather than…
What to include when your question involves a chromatogram Replied, post #37 · Start Here › How to Ask · 12 Jan 2026 · 2 likes Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method. Everything else follows from method. A chromatogram without…
The most common factual error about semaglutide on the internet — what changed since Replied, post #3 · Compounds › Semaglutide · 5 Jan 2026 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
A genuinely late dose: what the labelling says and what people do — what changed since Replied, post #10 · Practice › Administration · 26 Dec 2025 · 3 likes The arithmetic in post #7 is right; the assumption feeding it is the part to check. A genuinely late dose: the labelling generally says that if the next dose is more…
Tracking that stops updating and then resumes Replied, post #59 · Sourcing › Logistics · 23 Dec 2025 · 0 likes Worth separating two things that post #55 runs together. Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on…
How to read a phase 2 result without treating it as a phase 3 result Replied, post #18 · Compounds › Retatrutide · 5 Dec 2025 · 13 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #48 · Sourcing › Regulatory · 25 Nov 2025 · 3 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #6 · Practice › Side effects · 21 Nov 2025 · 1 like Nothing to add, except that this is the answer I would give if asked.
Second pass at: Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #6 · Compounds › Cagrilintide & amylin analogues · 19 Nov 2025 · 9 likes I read post #4 twice before replying, because I had assumed the opposite. Cagrilintide is a long-acting amylin analogue, which puts it in a different mechanistic family…
When to stop reading forums, including this one Replied, post #38 · Wellbeing › Mental health · 18 Oct 2025 · 16 likes Post #34 describes the usual case. This is about the unusual one. Relationship with food changing is one of the most commonly described experiences here and is…
The anatomy of a question that gets answered within an hour — the long version Replied, post #3 · Start Here › How to Ask · 16 Oct 2025 · 1 like Grateful for the specificity. Vague answers to this question are what sent me looking.
Can a home kit substitute for a laboratory report? A careful no Replied, post #18 · Analytics › Home & field testing · 25 Sep 2025 · 1 like Where a home observation and an independent result disagree, the independent one is measuring something more specific. That does not make the home observation useless —…
A parcel that arrived warm: a decision process, not a verdict Replied, post #52 · Practice › Storage & stability · 24 Sep 2025 · 4 likes Agreed, and I will stop repeating the version of this I had been repeating.
Aggregated purity results across four services, with caveats — a second dataset Replied, post #52 · Data & Tools › Datasets · 8 Sep 2025 · 7 likes Independent test results are the most valuable data this community collects, and they are only comparable when the method is captured alongside the number.
Why a compound being unapproved is not the same as being illegal to possess Replied, post #14 · Sourcing › Regulatory · 2 Sep 2025 · 0 likes A regulator's public assessment report is usually the single best free source on a compound's evidence base, and it is almost never cited here.
Confounding by indication, explained with a concrete example Replied, post #4 · Evidence › Study critique · 30 Aug 2025 · 17 likes Hold a trial to the standard something could actually have met. A criticism that no achievable design could have answered is a criticism of the field rather than of the…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #31 · Compounds › Oral incretins · 25 Aug 2025 · 19 likes Adding the measurement that post #30 says would settle it. Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not…
Comparing my trajectory with the trial curves, carefully Replied, post #39 · Outcomes › Progress reports · 22 Aug 2025 · 0 likes Where I part company with post #35, and it is a narrow parting. The best progress reports here read as records rather than as arguments, and that difference is visible…
Risk-of-bias tools and the judgement they conceal Replied, post #11 · Evidence › Meta-analyses · 17 Aug 2025 · 0 likes Where the risk-of-bias tools discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #24 · Practice › Storage & stability · 10 Aug 2025 · 2 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Warfarin and altered intake: the monitoring argument — the long version Replied, post #2 · Practice › Interactions · 8 Aug 2025 · 13 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. Agreed on Warfarin and altered intake, with one qualification that I think…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #78 · Compounds › Cagrilintide & amylin analogues · 3 Aug 2025 · 0 likes Research-use-only cagrilintide is not approved for human use and the published evidence base is a clinical-trial evidence base. Those two facts sit uncomfortably…
A ten-fold dose error caught before injection — one year on Replied, post #29 · Devices › Syringes & needles · 1 Aug 2025 · 5 likes Needle length for subcutaneous delivery is a question about tissue depth and injection angle together. Short needles at ninety degrees and longer ones at an angle reach…
Asking about a compound your prescriber has not heard of Replied, post #111 · Clinical › Prescriber conversations · 31 Jul 2025 · 0 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #66 · Compounds › Semaglutide · 12 Jul 2025 · 17 likes Narrowing post #65, because the general version has more than one answer. Practical experience of Semaglutide half-life, offered as one case with the conditions stated,…
Coming back to: What published stability data actually covers, and what it does not Replied, post #83 · Practice › Storage & stability · 9 Jul 2025 · 0 likes Answering the question post #82 raises rather than the one it answers. Small methodological point on published stability data actually covers: repeating a measurement…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #62 · Evidence › Journal club · 1 Jul 2025 · 3 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. The…
Second pass at: Reading a combination trial: attributing effect to components Replied, post #24 · Compounds › Cagrilintide & amylin analogues · 5 Jun 2025 · 0 likes Where I would push back on the Reading a combination trial consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Half-life, steady state, and accumulation worked through Replied, post #33 · Pharmacology › Pharmacokinetics · 28 May 2025 · 15 likes Where the half-life discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with…
Coming back to: Official shortage notices and what they authorise Replied, post #11 · Access › Shortages · 21 May 2025 · 6 likes Summarising the Official shortage notices thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it,…
Follow-up: Documentation that appears only after payment Replied, post #78 · Sourcing › Red flags · 14 May 2025 · 16 likes Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
Cost per milligram, computed honestly across formats — the long version Replied, post #93 · Access › Pricing · 8 May 2025 · 0 likes Adding the measurement that post #90 says would settle it. Independent testing is a real cost and belongs in the comparison. A cheaper supplier tested every lot may…
Carryover and the ghost peak from last week's standard Replied, post #65 · Analytics › HPLC & UHPLC · 9 Apr 2025 · 0 likes Post #64 answers the question as asked. The question underneath it is different. On carryover, the part that usually goes wrong is that the question is asked as though…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #104 · Access › International · 17 Mar 2025 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Maintainer handover: how it works Replied, post #32 · Meta › Wiki maintenance · 15 Mar 2025 · 15 likes A request rather than an answer: could whoever has the primary source for maintainer handover post it? I have seen the claim three times this month and each version had…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #35 · Compounds › Semaglutide · 10 Mar 2025 · 5 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
Checking someone else's arithmetic: a worked example thread Replied, post #22 · Practice › Reconstitution · 15 Feb 2025 · 0 likes Understood, and I withdraw the assumption I opened with.
Protein density versus volume when you cannot eat much Replied, post #27 · Nutrition & Training › Protein & intake · 27 Jan 2025 · 3 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
The topic list is dense — is that deliberate? Replied, post #87 · Meta › Site feedback · 23 Jan 2025 · 29 likes Post #84 is the version of this I will quote in future. One addition. Topic list is well covered in the tag pages, and the older discussions are better than the recent…
Holding a dose indefinitely: is there a documented downside? Replied, post #6 · Practice › Dosing & titration · 9 Jan 2025 · 1 like Everything in post #2 holds. The case it does not cover is the one I have. Micro-titration: the concept of increments smaller than the labelled steps. It has no…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #4 · marked as the solution · Compounds › Retatrutide · 9 Jan 2025 · 11 likes Triple agonism is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #2 · Compounds › Tirzepatide · 8 Jan 2025 · 32 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #95 · Access › Insurance & coverage · 30 Dec 2024 · 1 like Where the Step therapy requirements discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
Coming back to: When to suspect the method rather than the sample Replied, post #128 · Analytics › Method validation · 24 Dec 2024 · 0 likes Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one. The evidence for this is…
Building a sensible monitoring schedule with your prescriber Replied, post #94 · Clinical › Bloodwork · 22 Dec 2024 · 21 likes Having read the whole building a sensible monitoring schedule thread before replying: the question in the first post has not actually been answered yet, and three of us…
EMA product information as a primary source — does this still hold? Replied, post #12 · Regional › European Union · 14 Nov 2024 · 2 likes EMA product information is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #31 · Clinical › Prescriber conversations · 4 Nov 2024 · 29 likes Reading back through, this was answered upthread and I missed it. My fault.
Time to steady state after a dose increase Replied, post #20 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 15 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated… Replied, post #7 · Compounds › Secretagogues & GH axis · 2 Nov 2024 · 1 like Acetate versus trifluoroacetate is worth asking about for short peptides specifically, because the counter-ion is a larger proportion of the total mass at low molecular…
Here for the analytics and not much else — one year on Replied, post #2 · Lounge › Introductions · 18 Oct 2024 · 5 likes Hello and welcome. One practical suggestion: watch two subcategories rather than the whole site. The firehose is real and it puts people off in the first fortnight. On…
Irish differences from the UK position Replied, post #29 · Regional › UK & Ireland · 9 Oct 2024 · 7 likes Before the thread moves on from irish differences — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of…
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #36 · Analytics › Method validation · 20 Sep 2024 · 14 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #23 · Clinical › Special populations · 8 Sep 2024 · 3 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
The mass-error checker and its intended scope Replied, post #20 · Data & Tools › Calculators · 30 May 2024 · 20 likes Where I part company with post #16, and it is a narrow parting. Precision and significant figures: the calculators do not round to match your input precision. If you…